 SHANGHAI and SAN FRANCISCO, Sept. 16, 2021 GLOBE NEWSWIRE -- Zai Lab Limited NASDAQ: ZLAB; HKEX: 9688, an innovative commercial-stage biopharmaceutical company, announced today that it will expand its operations in the U.S. and establish a key presence in the Cambridge biotechnology hub. Business operations to be headquartered in the new Cambridge office include alliance management, business development, legal and governance functions. 